@FierceMedDev: Devicemaker Avinger pulled in $33M in fundraising to develop catheters. Item | Follow @FierceMedDev
@MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce
@DamianFierce: Abbott nabbed a CE mark for a new diabetes diagnostic the company says bests glucose monitors. Article | Follow @DamianFierce
> Pacific Biolabs is predicting that contract research organizations will see a boost in business from devicemakers, as the FDA requires more clinical trials before approval. News
> Researchers at Johns Hopkins say the latest generation of blood sugar-monitoring devices don't just require fewer needle pricks, they're also more effective than traditional methods. Article
> Integrity Life Sciences picked up 510(k) clearance for its Spinal Care System, a non-surgical spinal decompression device. More
> Pentax Medical has launched a new endoscopic ultrasound device in Europe, boasting that its slim insertion tube maximizes patient comfort. Release
> Israel's OrSense is unveiling its new wireless hemoglobin monitor, which, in trials, has demonstrated that it's as effective as invasive techs at identifying anemia and screening blood donors. Report
> A new diagnostic technique developed by scientists from Brown University and elsewhere uses immune cell DNA. Release
Biotech News
@FierceBiotech: Analysis: Top 20 biotech licensing deals in H1 2012 - a buyer's market dominates the deal scene. Special Report | Follow @FierceBiotech
@JohnCFierce: J&J licensing a portfolio of diabetes products from Evotec. $8M up, up to $300M down per product in milestones. Release | Follow @JohnCFierce
@RyanMFierce: Ipsen (France) and Inspiration Biopharma (Cambridge, MA) halt late-stage hemophilia drug trials, program in question. Story | Follow @RyanMFierce
> Ipsen shares slide after FDA orders hold on PhIII hemophilia drug trials. Article
> Struggling Chelsea jettisons staffers, plots survival strategy. Story
> Regulatory setback raises fresh questions about Sanofi R&D comeback. News
Pharma News
@FiercePharma: Can a new CEO turn Savient around? Regrouping after weak Krystexxa sales, Savient to lay off 35% of workforce. News | Follow @FiercePharma
> Amid Krystexxa woes, Savient plots layoffs and taps new CEO. More
> Forest CEO goes mano-a-mano with Carl Icahn. Item
> Novartis plant snafu sends desperate Excedrin users to eBay. Article
> Ranbaxy lines up plans for U.S. growth. Story
Pharma Manufacturing News
@EricPFierce: FDA warning letters , 483 reports can suggest a tipping point has been reached by a drug company. How about yours? Special Report | Follow @EricPFierce
> Ireland campus becomes Eli Lilly's launch pad. Story
> Abemarle again expands Michigan API plant. News
> AEI suggests booting WHO drugmakers that don't meet the grade. More
Biotech Research News
> Key molecule spotted as possible lung cancer weapon. Story
> Mouse model connects specific gene to liver cancer advance. Item
> Acadia's Parkinson's drug shows promise in treating Alzheimer's psychosis. More
> Nanomedicine busts deadly clots in promising mouse study. Article
And Finally... The Huffington Post highlights a number of new medical device implants under development or on the market that are designed to help address age-related ailments. Story